Relay Therapeutics Reports First Quarter 2024 Financial Results and Corporate Highlights
May 02, 2024 16:05 ET
|
Relay Therapeutics, Inc.
Relay Therapeutics Reports First Quarter 2024 Financial Results and Corporate Highlights
Inflammatory Bowel Disease Market To Exhibit Significant Growth by 2032, Predicts DelveInsight | Key Companies Developing Therapies - Arena Pharmaceuticals, Pfizer, Abivax, Janssen, Celgene, Eli Lilly and Company, Merck Sharp & Dohme LLC, T
May 02, 2024 13:00 ET
|
DelveInsight Business Research LLP
New York, USA, May 02, 2024 (GLOBE NEWSWIRE) -- Inflammatory Bowel Disease Market To Exhibit Significant Growth by 2032, Predicts DelveInsight | Key Companies Developing Therapies - Arena...
Shape Therapeutics Announces Appointment of Matt Valentino as Chief People Officer
May 02, 2024 08:00 ET
|
Shape Therapeutics, Inc.
SEATTLE, May 02, 2024 (GLOBE NEWSWIRE) -- Shape Therapeutics Inc. (ShapeTX), a leader at the convergence of AI and RNA editing to revolutionize genomic medicine, is pleased to announce the...
Muscular Dystrophy Association Launches ALS Awareness Month with Public Service Announcement ‘Answering the Call’
April 29, 2024 09:00 ET
|
Muscular Dystrophy Association
New York, April 29, 2024 (GLOBE NEWSWIRE) -- The Muscular Dystrophy Association (MDA) today announced programming and fundraising events in support of people living with Amyotrophic Lateral...
Biogen Receives Positive CHMP Opinion for TOFIDENCE™ (tocilizumab), a Biosimilar Referencing ROACTEMRA®
April 25, 2024 16:05 ET
|
Biogen Inc.
CHMP positive opinion is based on a robust analytical, non-clinical and clinical data package comparing TOFIDENCE™ to the reference product ROACTEMRA® CAMBRIDGE, Mass., April 25, 2024 (GLOBE...
Global Pulmonary Drugs Market is Expected to Showcase a Significant Growth by 2030, Predicts DelveInsight | Key Companies - F. Hoffmann-La Roche, AstraZeneca, Boehringer Ingelheim, GlaxoSmithKline, Sanofi, Grifols, Regeneron
April 25, 2024 13:00 ET
|
DelveInsight Business Research LLP
New York, USA, April 25, 2024 (GLOBE NEWSWIRE) -- Global Pulmonary Drugs Market is Expected to Showcase a Significant Growth by 2030, Predicts DelveInsight | Key Companies - F. Hoffmann-La Roche,...
Nucleome Therapeutics appoints Dr John Davis as Non-Executive Director of the Board and establishes Scientific Advisory Board of world-leading experts
April 25, 2024 07:00 ET
|
Nucleome Therapeutics
Nucleome Therapeutics appoints Dr John Davis as Non-Executive Director of the Board and establishes Scientific Advisory Board of world-leading experts John Davis brings direct clinical expertise as...
HDAC Inhibitor Market to Observe Stunning Growth During the Study Period (2020–2034) | DelveInsight
April 24, 2024 13:00 ET
|
DelveInsight Business Research LLP
New York, USA, April 24, 2024 (GLOBE NEWSWIRE) -- HDAC Inhibitor Market to Observe Stunning Growth During the Study Period (2020–2034) | DelveInsight According to DelveInsight’s analysis, the...
Gardner Syndrome Treatment Market Report 2024: Analysis and Forecast Through 2018-2033 Featuring Biochem Pharmaceuticals Industries, Zydus Lifesciences, Vernalis (R&D), Sun Pharmaceutical Industries, and Sanofi
April 24, 2024 04:09 ET
|
Research and Markets
Dublin, April 24, 2024 (GLOBE NEWSWIRE) -- The "Gardner Syndrome Treatment Global Market Report 2024" report has been added to ResearchAndMarkets.com's offering.The global Gardner syndrome...
[Ad hoc-Mitteilung gemäss Art. 53 KR] Verkäufe der Roche-Gruppe steigen im ersten Quartal um 2% (CER); beide Divisionen Pharma und Diagnostics wachsen im hohen einstelligen Bereich ohne COVID-19-Produkte
April 24, 2024 01:00 ET
|
F. Hoffmann-La Roche Ltd
Konzernverkäufe stiegen um 2%1 zu konstanten Wechselkursen (CER; -6% in CHF) dank starkem Wachstum der jüngeren Medikamente und Diagnostika; ohne COVID-19-Produkte nahmen die Konzernverkäufe um 7% zu;...